Delivery Order SPE2DB22D3501-SPE2DB25FXN25
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,365.73 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on July 22, 2025, with completion scheduled for July 23, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical supply transaction executed under the company's existing contract vehicle with DLA. The award was placed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,158.11 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 mcg spray (16 gm) on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a continuation of AmerisourceBergen's extensive supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,611.24 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 mcg spray (16 gm) on September 17, 2025, with an ultimate completion date of September 18, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's larger contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,244.88 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray in 16 GM units. This non-competitive award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a firm fixed-price delivery order under a larger indefinite delivery contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,010.88 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on September 5, 2025, with an ultimate completion date of September 8, 2025. The contract was awarded on a firm fixed price basis without any set-aside designation, indicating competitive award through open competition. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,331.36 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray in 16GM units. The contract was awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, and represents a firm fixed-price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order falls under a...
- The Defense Logistics Agency awarded a $2,073.60 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Fluticasone Propionate 50 MCG Spray in 16GM units. This is a firm fixed price, non-set-aside contract with a completion date of September 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a relatively modest procurement of this respiratory medication, which is commonly used in military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,010.88 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate 50 MCG Spray in 16GM units. This is a firm fixed-price, non-set-aside contract with a completion date of September 9, 2025, issued on September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms spray (16-gram unit) valued at $1,396.90 under a firm fixed-price contract type. This delivery order, issued on August 19, 2025, represents a non-competitive set-aside and carries an ultimate completion date of August 20, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,165.50 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate 50 MCG Spray (16 grams). This is a firm fixed-price, non-set-aside contract with a completion date of July 31, 2025, and was awarded on July 30, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting DLA's...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXN25Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,390.46 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on September 25, 2025, with an ultimate completion date of September 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen regularly fulfills such orders to support military healthcare systems and other government entities. The company's extensive IDC with DLA enables flexible delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/25/25 |